- Thermo Fisher Scientific will close its Franklin, Massachusetts, manufacturing facility and eliminate up to 80 positions, with layoffs occurring between December 31, 2026, and December 31, 2027.
- About 120 of the site’s 200 employees are expected to relocate to other Thermo Fisher facilities in Massachusetts as operations wind down by the end of 2026.
Thermo Fisher Scientific said it will close a manufacturing facility in Franklin, Massachusetts, and eliminate up to 80 positions as part of an ongoing effort to adjust its manufacturing footprint. The decision was disclosed in an updated state Worker Adjustment and Retraining Notification (WARN) notice. Layoffs tied to the closure are expected to occur between December 31, 2026, and December 31, 2027.
The Franklin site employs approximately 200 workers. Of those, around 120 are expected to relocate to other Thermo Fisher facilities in Massachusetts. The site is one of two company locations in the area and manufactures environmental and process monitoring equipment.
The company said the closure reflects current customer demand and an ongoing review of its global operations to improve efficiency. Operations at the Franklin site will be phased out by the end of 2026, with much of the work shifting to other U.S. manufacturing locations. Thermo Fisher said affected employees will receive job-transition support and that the move does not indicate a broader pullback from U.S. manufacturing.
The announcement follows other recent workforce reductions. In the past year, Thermo Fisher reduced about 300 roles at viral vector manufacturing sites in Cambridge and Plainville, Massachusetts, and closed a viral vector facility in Lexington, Massachusetts, affecting 160 positions. More recently, the company said it will close a lab equipment manufacturing plant in Asheville, North Carolina, eliminating 421 jobs by the end of 2027.
Even as it reduces capacity at some locations, Thermo Fisher has expanded elsewhere. In 2025, the company acquired a sterile fill-finish and packaging facility from Sanofi in Ridgefield, New Jersey, taking on about 200 employees as part of a plan to invest an additional $2 billion in U.S. operations over four years.
